COMPANY
Clinical Phase 1
Profile checked Oct 10, 2026
Keywords: Triple Negative Breast Cancer Urothelial Cancer Cervical Cancer ADRX-0706 ADRX-0405
Timeline
- Trial start Phase 1: A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors source ↗
- Trial start Phase 1: A Study of ADRX-0706 in Select Advanced Solid Tumors source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT06036121 | A Study of ADRX-0706 in Select Advanced Solid Tumors | Phase 1 | Active, not recruiting | Sep 26, 2023 | 2025-09 (estimated) |
| NCT06710379 | A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors | Phase 1 | Recruiting | Dec 30, 2024 | 2026-07 (estimated) |